Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 33

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 33
---
 the nominating and corporate governance committee and key findings and observations are reported to the full board of directors for discussion and action, if appropriate. This process has resulted in several meaningful improvements to the effectiveness of meetings of our board of directors and timing and means of providing information to the board of directors.

Director Orientation and Continuing Education

We do not currently intend to adopt a formal orientation and continuing education program for new directors. However, it is expected that all new directors will be given training which will include background material on our policies and procedures, written information about the duties and obligations of members of our board of directors, our business and operations, as well as documents from recent meetings of our board of directors. New directors will also visit our facilities and have access to management to discuss the activities of Repare and the organization. Directors are encouraged to be involved in continuing director education on an ongoing basis, and we intend to pay all reasonable expenses related to continuing director education.

Human Capital Management

As of April 15, 2025, we had 102 regular full-time employees, including 36 who hold an M.D. or Ph.D. degree. Of these full-time employees, 78 were primarily engaged in research and development activities and 24 were primarily engaged in management or general and administrative activities. As announced in February 2025, we are currently implementing a phased reorganization plan, pursuant to which we expect to reduce our workforce to under 30 full-time employees by the fourth quarter of 2025.

Commitment to Culture, Competitive Compensation, Employee Benefits and Well-Being

We strive to offer competitive compensation packages. In addition to competitive base salaries, the other competitive benefits that we provide to all employees include annual equity and cash incentive plans, comprehensive healthcare and insurance benefits, retirement benefits, an employee share purchase plan and paid time off. Beyond compensation and benefits, we also provide access to training, continuous learning programs, lunch & learn sessions, tuition reimbursement and other development initiatives. We routinely assess employee turnover, recruitment initiatives, employee engagement, compensation and benefits programs and other matters relevant to human capital management, and we review results with our board of directors on a periodic basis.

Health and Safety

We are committed to strict policies and procedures to maintain a safe working environment. The health and safety of our employees, patients and communities are of primary concern. Many of our employees work in our**

<div align='center'>22</div>

**laboratory facilities in Montreal. All laboratory personnel are regularly trained in chemical safety, the use of personal protective